Clinical Trial Update: PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pharmacological lowering of advanced glycation end products (AGEs) in diabetes and related conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy
• Diabetic Retinopathy

Snippet

Sponsor: University of Chile | Conditions: DIABETES, DIABETIC RETINOPATHY | Phase 4 | Status: COMPLETED